Karuna Therapeutics, Inc. (NASDAQ:KRTX – Free Report) – Equities researchers at Cantor Fitzgerald lowered their FY2023 EPS estimates for Karuna Therapeutics in a report issued on Wednesday, November 8th. Cantor Fitzgerald analyst C. Duncan now expects that the company will post earnings of ($11.02) per share for the year, down from their prior estimate of […]
Karuna Therapeutics (NASDAQ:KRTX – Get Free Report) had its price target reduced by equities researchers at Royal Bank of Canada from $235.00 to $225.00 in a report released on Friday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Royal Bank of Canada’s price target would suggest a potential upside of 21.35% […]
Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Free Report) was the recipient of a large growth in short interest in the month of September. As of September 30th, there was short interest totalling 1,670,000 shares, a growth of 18.4% from the September 15th total of 1,410,000 shares. Based on an average daily volume of 252,200 shares, […]
HC Wainwright reissued their buy rating on shares of Karuna Therapeutics (NASDAQ:KRTX – Free Report) in a research report sent to investors on Thursday morning, Benzinga reports. The firm currently has a $300.00 target price on the stock. Several other research firms also recently weighed in on KRTX. Cantor Fitzgerald reiterated a neutral rating and […]
Karuna Therapeutics, Inc (NASDAQ:KRTX) Receives $260 50 Consensus PT from Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.